Orally Deliverable Dual-Targeted Pellets for the Synergistic Treatment of Ulcerative Colitis

References

• AbrahamC, ChoJH. Inflammatory bowel disease. N Engl J Med. 2009;361(21):2066–2078. doi:10.1056/NEJMra080464719923578
   PubMed Web of Science ®Google Scholar
• SiciliaB, Garcia-LopezS, Gonzalez-LamaY, ZabanaY, HinojosaJ, GomollonF. GETECCU 2020 guidelines for the treatment of ulcerative colitis developed using the GRADE approach. Gastroenterol Hepatol. 2020;43(Suppl 1):1–57. doi:10.1016/j.gastrohep.2020.07.001
   Web of Science ®Google Scholar
• GajendranM, LoganathanP, JimenezG, et al. A comprehensive review and update on ulcerative colitis(). Dis Mon. 2019;65(12):100851. doi:10.1016/j.disamonth.2019.02.00430837080
   PubMed Web of Science ®Google Scholar
• HanW, XieB, LiY, ShiL, WangH. Orally deliverable nanotherapeutics for the synergistic treatment of colitis-associated colorectal cancer. Theranostics. 2019;9(24):7458–7473. doi:10.7150/thno.3808131695780
   PubMed Web of Science ®Google Scholar
• GrivennikovSI. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol. 2013;35:229–244.23161445
   PubMed Web of Science ®Google Scholar
• DaneseS, MantovaniA. Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer. Oncogene. 2010;29(23):3313–3323. doi:10.1038/onc.2010.10920400974
   PubMed Web of Science ®Google Scholar
• PorterRJ, KallaR, HoGT. Ulcerative colitis: recent advances in the understanding of disease pathogenesis. F1000Res. 2020;9:294. doi:10.12688/f1000research.20805.1
   Google Scholar
• WangR, ZhouG, WangM, PengY, LiX. The metabolism of polysaccharide from Atractylodes macrocephala Koidz and its effect on intestinal microflora. Evid Based Compl Alt. 2014;2014:1–7.
   Web of Science ®Google Scholar
• ZhangL, CaoN, WangY, et al. Improvement of oxazolone-induced ulcerative colitis in rats using andrographolide. Molecules. 2020;25(1):76. doi:10.3390/molecules25010076
   Web of Science ®Google Scholar
• KringelDH, AntunesMD, KleinB, et al. Production, characterization, and stability of orange or eucalyptus essential oil/beta-cyclodextrin inclusion complex. J Food Sci. 2017;82(11):2598–2605. doi:10.1111/1750-3841.1392329083485
   PubMed Web of Science ®Google Scholar
• TanS, YuW, LinZ, et al. Berberine ameliorates intestinal mucosal barrier damage induced by peritoneal air exposure. Biol Pharm Bull. 2015;38(1):122–126. doi:10.1248/bpb.b14-0064325341882
   PubMed Web of Science ®Google Scholar
• LiYH, XiaoH, HuD, et al. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses. Pharmacol Res. 2016;110:S1943242085.
   Web of Science ®Google Scholar
• LiaoZ, XieY, ZhouB, et al. Berberine ameliorates colonic damage accompanied with the modulation of dysfunctional bacteria and functions in ulcerative colitis rats. Appl Microbiol Biotechnol. 2020;104(4):1737–1749. doi:10.1007/s00253-019-10307-131867696
   PubMed Web of Science ®Google Scholar
• LeopoldCS, EikelerD. Basic coating polymers for the colon-specific drug delivery in inflammatory bowel disease. Drug Dev Ind Pharm. 2000;26(12):1239–1246. doi:10.1081/DDC-10010230511147124
   PubMed Web of Science ®Google Scholar
• YangL, ChuJS, FixJA. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharmaceut. 2002;235(1):1–15. doi:10.1016/S0378-5173(02)00004-2
   Web of Science ®Google Scholar
• LeeSH, BajracharyaR, MinJY, HanJW, ParkBJ, HanHK. Strategic approaches for colon targeted drug delivery: an overview of recent advancements. Pharmaceutics. 2020;12(1):68.
   PubMed Web of Science ®Google Scholar
• WangQ, WangG, ZhouJ, GaoL, CuiY. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis. Int J Pharmaceut. 2016;515(1–2):176–185. doi:10.1016/j.ijpharm.2016.10.002
   PubMed Web of Science ®Google Scholar
• XiaoB, MerlinD. Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease. Expert Opin Drug Del. 2012;9(11):1393–1407. doi:10.1517/17425247.2012.730517
   PubMed Web of Science ®Google Scholar
• PandeyS, SwamyS, GuptaA, et al. Multiple response optimisation of processing and formulation parameters of pH sensitive sustained release pellets of capecitabine for targeting colon. J Microencapsul. 2018;35(3):259–271. doi:10.1080/02652048.2018.146513829659317
   PubMed Web of Science ®Google Scholar
• SunX, LiuC, OmerAM, et al. pH-sensitive ZnO/carboxymethyl cellulose/chitosan bio-nanocomposite beads for colon-specific release of 5-fluorouracil. Int J Biol Macromol. 2019;128:468–479. doi:10.1016/j.ijbiomac.2019.01.14030695723
   PubMed Web of Science ®Google Scholar
• MoghimipourE, RezaeiM, KouchakM, et al. Effects of coating layer and release medium on release profile from coated capsules with Eudragit FS 30D: an in vitro and in vivo study. Drug Dev Ind Pharm. 2018;44(5):861–867. doi:10.1080/03639045.2017.141592729235889
   PubMed Web of Science ®Google Scholar
• WanD, ZhaoM, ZhangJ, LuanL. Development and in vitro-in vivo evaluation of a novel sustained-release loxoprofen pellet with double coating layer. Pharmaceutics. 2019;11(6):260. doi:10.3390/pharmaceutics11060260
   Web of Science ®Google Scholar
• SegaleL, ManninaP, GiovannelliL, MuschertS, PattarinoF. Formulation and coating of alginate and alginate-hydroxypropylcellulose pellets containing ranolazine. J Pharm Sci US. 2016;105(11):3351–3358. doi:10.1016/j.xphs.2016.08.001
   Web of Science ®Google Scholar
• KimY, PradhanR, PaudelBK, ChoiJY, ImHT, KimJO. Preparation and evaluation of enteric-coated delayed-release pellets of duloxetine hydrochloride using a fluidized bed coater. Arch Pharm Res. 2015;38(12):2163–2171. doi:10.1007/s12272-015-0590-y26183280
   PubMed Web of Science ®Google Scholar
• MelegariC, BertoniS, GenovesiA, et al. Ethylcellulose film coating of guaifenesin-loaded pellets: a comprehensive evaluation of the manufacturing process to prevent drug migration. Eur J Pharm Biopharm. 2016;100:15–26. doi:10.1016/j.ejpb.2015.12.00126686647
   PubMed Web of Science ®Google Scholar
• BelewS, SulemanS, DugumaM, et al. Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets. Malar J. 2020;19(1):139. doi:10.1186/s12936-020-03209-532264882
   PubMed Web of Science ®Google Scholar
• VerstraeteG, De JaeghereW, VercruysseJ, et al. The use of partially hydrolysed polyvinyl alcohol for the production of high drug-loaded sustained release pellets via extrusion-spheronisation and coating: in vitro and in vivo evaluation. Int J Pharmaceut. 2017;517(1–2):88–95. doi:10.1016/j.ijpharm.2016.11.067
   Web of Science ®Google Scholar
• NovobilskyA, HoglundJ. Small animal in vivo imaging of parasitic infections: a systematic review. Exp Parasitol. 2020;214:107905. doi:10.1016/j.exppara.2020.10790532387050
   PubMed Web of Science ®Google Scholar
• KarroutY, DubuquoyL, PiveteauC, et al. In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy. J Control Release. 2015;197:121–130. doi:10.1016/j.jconrel.2014.11.00625445696
   PubMed Web of Science ®Google Scholar
• PanduranganAK, IsmailS, SaadatdoustZ, EsaNM. Allicin alleviates dextran sodium sulfate- (DSS-) induced ulcerative colitis in BALB/c mice. Oxid Med Cell Longev. 2015;2015:605208. doi:10.1155/2015/60520826075036
   PubMed Web of Science ®Google Scholar
• FerriD, CosteroAM, GavinaP, et al. Efficacy of budesonide-loaded mesoporous silica microparticles capped with a bulky azo derivative in rats with TNBS-induced colitis. Int J Pharm. 2019;561:93–101. doi:10.1016/j.ijpharm.2019.02.03030817986
   PubMed Web of Science ®Google Scholar
• Shi C, Liang Y, Yang J, et al. MicroRNA-21 knockout improve the survival rate in DSS induced fatal colitis through protecting against inflammation and tissue injury. Plos One. 2013;8(6):e66814. doi:10.1371/journal.pone.006681423826144
   PubMed Web of Science ®Google Scholar
• Nunes NS, Chandran P, Sundby M, et al. Therapeutic ultrasound attenuates DSS-induced colitis through the cholinergic anti-inflammatory pathway. Ebiomedicine. 2019;45:495–510. doi:10.1016/j.ebiom.2019.06.03331253515
   PubMed Web of Science ®Google Scholar
• Li X, Xu Y, Zhang C, et al. Protective Effect of Calculus Bovis Sativus on Dextran Sulphate Sodium-Induced Ulcerative Colitis in Mice. Evid-Based Compl Alt. 2015;2015:Article ID 469506. doi:10.1155/2015/469506
   Web of Science ®Google Scholar
• Gao W, Wang C, Yu L, et al. Chlorogenic Acid Attenuates Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice through MAPK/ERK/JNK Pathway. Biomed Res Int. 2019;2019:Article ID: 6769789. doi:10.1155/2019/6769789
   Web of Science ®Google Scholar
• Ke J, Bian X, Liu H, et al. Edaravone reduces oxidative stress and intestinal cell apoptosis after burn through up-regulating miR-320 expression. Mol Med. 2019;25:54. doi:10.1186/s10020-019-0122-131829167
   PubMed Web of Science ®Google Scholar
• Kverka M, Rossmann P, Tlaskalova-Hogenova H, et al. Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis. Bmc Gastroenterol. 2011;11(1):47. doi:10.1186/1471-230X-11-4721545711
   PubMed Web of Science ®Google Scholar
• Banerjee A, Bizzaro D, Burra P, et al. Umbilical cord mesenchymal stem cells modulate dextran sulfate sodium induced acute colitis in immunodeficient mice. Stem Cell Res Ther. 2015;6:79. doi:10.1186/s13287-015-0073-625890182
   PubMed Web of Science ®Google Scholar
• NeurathMF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14(5):329–342. doi:10.1038/nri366124751956
   PubMed Web of Science ®Google Scholar
• KramarA, TurkS, VrečerF. Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films. Int J Pharmaceut. 2003;256(1–2):43–52. doi:10.1016/S0378-5173(03)00061-9
   Web of Science ®Google Scholar
• WangX, LuoZ, XiaoZ. Preparation, characterization, and thermal stability of β-cyclodextrin/soybean lecithin inclusion complex. Carbohyd Polym. 2014;101:1027–1032. doi:10.1016/j.carbpol.2013.10.042
   PubMed Web of Science ®Google Scholar
• KumarA, EkavaliCK, MukherjeeM, PottabathiniR, DhullDK, DhullDK. Current knowledge and pharmacological profile of berberine: an update. Eur J Pharmacol. 2015;761:288–297. doi:10.1016/j.ejphar.2015.05.06826092760
   PubMed Web of Science ®Google Scholar
• LauberDT, FulopA, KovacsT, SzigetiK, MatheD, SzijartoA. State of the art in vivo imaging techniques for laboratory animals. Lab Anim. 2017;51(5):465–478. doi:10.1177/002367721769585228948893
   PubMed Web of Science ®Google Scholar
• ArakiA, NaraH, RahmanM, et al. Role of interleukin-21 isoform in dextran sulfate sodium (DSS)-induced colitis. Cytokine. 2013;62(2):262–271. doi:10.1016/j.cyto.2013.03.00623557800
   PubMed Web of Science ®Google Scholar
• PervinM, HasnatMA, LimJH, et al. Preventive and therapeutic effects of blueberry (Vaccinium corymbosum) extract against DSS-induced ulcerative colitis by regulation of antioxidant and inflammatory mediators. J Nutr Biochem. 2016;28:103–113. doi:10.1016/j.jnutbio.2015.10.00626878787
   PubMed Web of Science ®Google Scholar
• GongY, NiuW, TangY, et al. Aggravated mucosal and immune damage in a mouse model of ulcerative colitis with stress. Exp Ther Med. 2019;17(3):2341–2348.30783488
   PubMed Web of Science ®Google Scholar